CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer
Roy Kessous, Michel D. Wissing, Sabrina Piedimonte, Jeremie Abitbol, Liron Kogan, Ido Laskov, Amber Yasmeen, Shannon Salvador, Susie Lau, Walter H. Gotlieb
Research output: Contribution to journal › Article › peer-review
19Scopus
citations
Fingerprint
Dive into the research topics of 'CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer'. Together they form a unique fingerprint.